Latest News

TAR-200 boasts impressive DFS rates in papillary disease-only NMIBC
TAR-200 boasts impressive DFS rates in papillary disease-only NMIBC

April 30th 2025

Data showed a disease-free survival rate of 85.3% at 6 months and 81.1% at 9 months.

Pearls & Perspectives: Advancing sexual health in urology, with Rachel Rubin, MD, at AUA 2025
Pearls & Perspectives: Advancing sexual health in urology, with Rachel Rubin, MD, at AUA 2025

April 29th 2025

Pearls & Perspectives: innovation in male fertility care with Larry Lipshultz, MD, at AUA 2025
Pearls & Perspectives: Innovation in male fertility care with Larry Lipshultz, MD, at AUA 2025

April 29th 2025

Man talking with a doctor | Image Credit: © Pcess609 - stock.adobe.com
Ultra-low PSA responses are more prevalent with darolutamide plus ADT

April 29th 2025

Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
Cxbladder Triage may help patients avoid unnecessary cystoscopies

April 29th 2025

Latest Videos

Latest News

© 2025 MJH Life Sciences

All rights reserved.